Stock Market News To Give You An Edge

Proven Track Record of Most Accurate Analysis

Stock Market News
To Give You An Edge​

Proven Track Record
of Most Accurate Analysis

COMPLETELY INDEPENDENT AND OBJECTIVE

The Arora Report, Ltd. is a rare publisher that does not accept advertisements. This way The Arora Report can not be influenced. The Arora Report also does not accept payments from any company that is the subject of the posts. The Arora Report has forsaken millions of dollars in revenues to avoid conflicts of interest. Our sole job is to help you. Read more.

COMPLETELY INDEPENDENT AND OBJECTIVE

The Arora Report, Ltd. is a rare publisher that does not accept advertisements. This way The Arora Report can not be influenced. The Arora Report also does not accept payments from any company that is the subject of the posts. The Arora Report has forsaken millions of dollars in revenues to avoid conflicts of interest. Our sole job is to help you. Read more.

12.5% GAIN ON $BSX (BOSTON SCIENTIFIC) IN THE FACE OF SEVERAL BROKER DOWNGRADES

In spite of a negative article in Barron’s Online and two new broker downgrades, we have 12.5% gain at $7.10. This illustrates the power of ZYX Change Method. ZYX Change Method calls for protecting the gains. We scaled in 20% of the full position. Per the trade methodology of ZYX change Method, it is prudent to sell 10% of the full position size or half of the existing $7.10. Tight stops on the rest. www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every

Read More »

ANATOMY OF $BSX (BOSTON SCIENTIFIC), $MDT (MEDTRONIC) AND $STJ (ST. JUDE MEDICAL) TRADES BASED ON ZYX CHANGE METHOD

In ZYX Change Method, every trade must pass through six screens. In the first Change Screen, we are looking for macro changes. In this case, our long time readers know that we have been negative on medical devices industry because we anticipate going forward macro environment will not be conducive to maintaining present margins. The only exception has been $BSX (Boston Scientific) as we have anticipated improving margins. The second screen is Fund Flow Analysis Screen. Here we are using proprietary indicators to dissect money flow. We have been seeing negative Fund Flow Indicators on $MDT (Medtronic) and $STJ (St.

Read More »

AS PER THE PRIOR POST, ADDED TO $MDT SHORT AT $46.00

www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since 2007, without exception, is included in the performance results. Number of winning positions: 162 Number of losing positions: 10 Average annualized % return per position: 296.77% ………………Check out details .

Read More »

AS PER THE PRIOR POST, SCALED IN A SHORT ON $STJ AT 40.70

www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since 2007, without exception, is included in the performance results. Number of winning positions: 162 Number of losing positions: 10 Average annualized % return per position: 296.77% ………………Check out details .

Read More »

AS PER THE PRIOR POST, SCALED IN LONG ON $BSX AT $6.32

www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since 2007, without exception, is included in the performance results. Number of winning positions: 162 Number of losing positions: 10 Average annualized % return per position: 296.77% ………………Check out details .

Read More »

SHORT SELL $STJ AND $MDT, BUY $BSX

$BSX is down substantially on FDA issues and competitors $MDT and $STJ have spiked up. These are minor paperwork issues and will not have a long term impact. Scale in on $BSX on dips. Scale in on $MDT and $STJ on spikes. www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since 2007, without exception, is included in the performance results. Number of winning positions: 162 Number of losing positions: 10 Average annualized % return per position: 296.77% ………………Check out details

Read More »

MORE EVIDENCE TO SUPPORT OUR THEORY OF DISINTERMEDIATION OF PHARMACY BENEFIT MANAGERS IN THE LONG TERM

We have been short with a very long term perspective on pharmacy benefit managers $MHS and $ESRX. The point of ZYX Change metod is all about catching the change ahead of the crowd. Our theory is that in the long term pharmacy benefit managers will be disintermediated and their opaqueness will move their clients to other newer pharmacy benrfit managers who provide price transparency to their clients. Recent earnings from $SXCI support the opaqueness theory. Now, today following is the news from $WAG: Delta in talks over prescription drug plan, sources says – DJ (34.39 ) : DJ reports Delta

Read More »

TRADE MANAGEMENT UNDER ZYX CHANGE METHOD

Earlier today we sold $NFLX short at $71.20. Shortly afterwards $NFLX was touted as a buy because of Cisco announcement. Anyone following ZYX Change method would have taken advantage of the temporary move up to add to the short position. And when the move up failed, it was an opportunity to add more per the ZYX method. Since it is a volatile stock, we will not lower stops on the core position, but trail stops on some of the rest and tighten fixed stop on another partial. One of the axioms of the ZYX Change method is to not let

Read More »

AI is power hungry. Investors will make a fortune from nuclear power for AI.
Get the list of 12 nuclear power stocks to grab your share of the profits.

AI is power hungry. Investors will make a fortune from nuclear power for AI.

Get the list of 12 nuclear power stocks to grab your share of the profits.

Big Tech is investing billions

Making A Fortune
In Nuclear Energy

Golden Age of Nuclear Energy

Skip to content